Vaccine Technology III
Call for Abstracts

Sterilization Procedures:
Technology, Equipment and Validation

Bioassays 2009: Scientific Approaches & Regulatory Strategies

Jobs at the Center for Biologics Evaluation and Research (CBER)

High-Performance Platinum-Cured
Silicone Tubing: The Next Generation

Free Antibody Promotion

WEBCAST: How to Systematically Assess Raw Material Risk

Authentication and Characterization of Animal Cell Lines:
The Impact on Research

By Yvonne A. Reid, PhD (yreid@atcc.org), Collection/Research Scientist, Cell Biology Program; ATCC, Manassas, Virginia.

Applying Modern Design of Experiments to Mass Transfer Characterization in Bioreactors

By Priyal Sheth, associate bioprocess engineer; and Semsi Ensari, PhD, (semsi.ensari@Ambrx.com) senior bioprocess engineer; Ambrx, Inc., La Jolla, California.

A leader in single-use mixing, storage and
bioreactor technology, ATMI LifeSciences
doubles its manufacturing capacity:

With upgrades and modifications to its North American manufacturing facility in Bloomington, Minnesota, ATMI LifeSciences is responding to growing U.S. demand for disposable bioprocess vessels while doubling its worldwide production capacity. The site has added a Grade B clean room for fabricating complex three-dimensional storage, mixing and bioreactor vessels, and has created an on-site quality testing laboratory to analyze and manage sterility levels in the manufacturing environment. In addition, the company continues to manufacture bioprocess vessels at its facility in Belgium. The time-frame for shipping commercial products from the North American facility is expected to be in 2010.

Using fluoropolymer-based products and custom-engineered, flexible packaging solutions, ATMI LifeSciences is a leader in single-use mixing, storage, and bioreactor technology. The company’s fundamental knowledge of polymers, specially selected resins, and clean room manufacturing technology combine to produce the highest quality products for critical process operations. For more information, please visit www.atmi-lifesciences.com or contact Jeff Craig, ATMI LifeSciences, Global Director, Life Sciences Marketing and Business Development at JCraig@atmi.com.  

Sigma-Aldrich Receives Award From
Michael J. Fox Foundation to Develop
Parkinson’s Disease Research Models

For more info, visit www.sigma.com/sagelabs

SUBMISSIONS:

Please submit materials via email to the-techie@biotechnoblog.net, but be sure to zip the file if it exceeds 2 MB.  Another option is to mail us the file on a key drive, but note that we won’t return your drive since we collect them and it isn’t worth the handling cost.  And then you can upload the file to your FTP site and send us the URL and password we’ll need to download it.  Or you can simply email us a link so we can view the material on another website.  Depending on the content and format of the material, we will post links to wherever it can best be viewed or downloaded.   

All submissions must address a recent advancement or solidify a “best practice” for biologic product development or production. The material format can be streaming video, YouTube postings, automated PowerPoint presentations; as well as PDF, HTML, Word and Excel docs. Be sure to include complete contact information for the corresponding submitter, an introduction of no more than 75 words, and a list of key words.

REVIEWERS:

If you would like to help review submissions for a specific application or technology area, please contact the-boss@biotechnoblog.net. Include your full contact information, the area(s) in which you would like to contribute, and any relevant experience you’ve had on a review or advisory board.

ADVERTISING AND SPONSORSHIPS:

Please contact the-closer@biotechnoblog.net to get a quote for advertising or to sponsor our efforts.

CONTACT US:

We hope you enjoy visiting our site and find the content both valuable and timely. We are committed to posting the best technical content we can collect as we do our best to make your interaction a pleasurable experience. We look forward to reading your comments at the-boss@biotechnoblog.net.